Skip to content
OpenCapital
Get started

Arcadia Biosciences RKDA Q3 2025 earnings

Reported November 7, 2025 · Before market open

Revenue$1.3MMiss by $598.0K
EPS$0.62Beat by $1.16
Revenue estimate$1.9M
EPS estimate-$0.54

Next report

Aug 19, 2026 (In 2 weeks)
Revenue estimate$1.9M
EPS estimate-$0.56

Versus estimates

Revenue

Q1 2026$1.1MMiss by $500.0KQ4 2025$901.0KMiss by $499.0K
Q3 2025$1.3MMiss by $598.0K
Q2 2025$1.5MMiss by $745.0KQ1 2025$1.2MMiss by $100.0KQ4 2024$1.2MBeat by $66.0K

Diluted EPS

Q1 2026-$2.11Miss by $1.31Q4 2025-$0.98Miss by $0.32
Q3 2025$0.62Beat by $1.16
Q2 2025$0.02Beat by $0.81Q1 2025$1.90Beat by $2.88Q4 2024-$2.48Miss by $1.59

Ask the moment Arcadia Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Arcadia Biosciences report Q3 2025 earnings?
Arcadia Biosciences (RKDA) reported Q3 2025 earnings on November 7, 2025 before market open.
What were Arcadia Biosciences's Q3 2025 revenue and EPS?
Arcadia Biosciences reported revenue of $1.3M and eps of $0.62 for Q3 2025.
Did Arcadia Biosciences beat estimates in Q3 2025?
Revenue missed the consensus estimate of $1.9M by $598.0K. EPS beat the consensus estimate of $-0.54 by $1.16.
How did Arcadia Biosciences's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 15.3% from $1.5M a year earlier.
Where can I find Arcadia Biosciences's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-272368) and the 10-Q periodic report (0001193125-25-272375) directly on SEC EDGAR. The filing index links above go to sec.gov.